On September 5, 2023, Bridge Biotherapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
62,600 KRW | -1.26% |
|
-6.57% | -3.69% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.69% | 165.08Cr | |
+16.42% | 12TCr | |
+19.02% | 11TCr | |
+3.14% | 2.27TCr | |
-16.20% | 2.13TCr | |
-39.57% | 1.69TCr | |
-11.63% | 1.67TCr | |
-16.15% | 1.66TCr | |
+2.68% | 1.36TCr | |
+21.16% | 1.1TCr |
- Stock Market
- Equities
- A141080 Stock
- News LigaChem Biosciences Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 5.9999904 billion in funding from LegoChem Biosciences, Inc.